Publicaciones en colaboración con investigadores/as de University of Oxford (5)

2023

  1. N-aryltetrahydroisoquinoline derivatives as HA-CD44 interaction inhibitors: Design, synthesis, computational studies, and antitumor effect

    European Journal of Medicinal Chemistry, Vol. 258

2022

  1. Selective Anticancer Therapy Based on a HA-CD44 Interaction Inhibitor Loaded on Polymeric Nanoparticles

    Pharmaceutics, Vol. 14, Núm. 4

2013

  1. Selective small molecule probes for the hypoxia inducible factor (HIF) Prolyl Hydroxylases

    ACS Chemical Biology, Vol. 8, Núm. 7, pp. 1488-1496

2010

  1. Structural basis for binding of cyclic 2-oxoglutarate analogues to factor-inhibiting hypoxia-inducible factor

    Bioorganic and Medicinal Chemistry Letters, Vol. 20, Núm. 20, pp. 6125-6128

2008

  1. Evaluation of aspirin metabolites as inhibitors of hypoxia-inducible factor hydroxylases

    Chemical Communications, pp. 6393-6395